INE600L01024
INE600L01024
DR. LAL PATH LABS LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 323.32B EUR | 274.91B EUR | 219.09B EUR | 247.56B EUR |
Enterprise Value | 311.88B EUR | 274.91B EUR | 218.65B EUR | 247.56B EUR |
Valuation Multiples | ||||
Trailing P/E | 59.68x | 70.25x | 61.86x | 65.54x |
Forward P/E | 44.16x | -- | -- | -- |
Price to Sales | 11.18x | 12.73x | 10.78x | 12.81x |
Price to Book | 12.87x | -- | 8.74x | -- |
EV/Revenue | 10.79x | 12.73x | 10.76x | 12.81x |
EV/EBITDA | 39.48x | 39.62x | 34.44x | 40x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |